Literature DB >> 20233940

Changes in skeletal muscle mitochondria in response to the development of type 2 diabetes or prevention by daily wheel running in hyperphagic OLETF rats.

R Scott Rector1, Grace M Uptergrove, Sarah J Borengasser, Catherine R Mikus, E Matthew Morris, Scott P Naples, Matthew J Laye, M Harold Laughlin, Frank W Booth, Jamal A Ibdah, John P Thyfault.   

Abstract

The temporal changes in skeletal muscle mitochondrial content and lipid metabolism that precede type 2 diabetes are largely unknown. Here we examined skeletal muscle mitochondrial fatty acid oxidation (MitoFAOX) and markers of mitochondrial gene expression and protein content in sedentary 20- and 40-wk-old hyperphagic, obese Otsuka Long-Evans Tokushima fatty (OLETF-SED) rats. Changes in OLETF-SED rats were compared with two groups of rats who maintained insulin sensitivity: age-matched OLETF rats given access to voluntary running wheels (OLETF-EX) and sedentary, nonobese Long-Evans Tokushima Otsuka (LETO-SED) rats. As expected, glucose tolerance tests revealed insulin resistance at 20 wk that progressed to type 2 diabetes at 40 wk in the OLETF-SED, whereas both the OLETF-EX and LETO-SED maintained whole body insulin sensitivity. At 40 wk, complete MitoFAOX (to CO(2)), beta-hydroxyacyl-CoA dehydrogenase activity, and citrate synthase activity did not differ between OLETF-SED and LETO-SED but were significantly (P < 0.05) higher in OLETF-EX compared with OLETF-SED rats. Genes controlling skeletal muscle MitoFAOX (PGC-1alpha, PPARdelta, mtTFA, cytochrome c) were not different between OLETF-SED and LETO-SED at any age. Compared with the OLETF-SED, the OLETF-EX rats had significantly (P < 0.05) higher skeletal muscle PGC-1alpha, cytochrome c, and mtTFA mRNA levels at 20 and 40 wk and PPARdelta at 40 wk; however, protein content for each of these markers did not differ between groups at 40 wk. Limited changes in skeletal muscle mitochondria were observed during the transition from insulin resistance to type 2 diabetes in the hyperphagic OLETF rat. However, diabetes prevention through increased physical activity appears to be mediated in part through maintenance of skeletal muscle mitochondrial function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233940      PMCID: PMC2886529          DOI: 10.1152/ajpendo.00703.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  35 in total

Review 1.  Global and societal implications of the diabetes epidemic.

Authors:  P Zimmet; K G Alberti; J Shaw
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats.

Authors:  L P Turcotte; J R Swenberger; M Zavitz Tucker; A J Yee
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

3.  Skeletal muscle oxidative capacity in rats fed high-fat diet.

Authors:  S Iossa; M P Mollica; L Lionetti; R Crescenzo; M Botta; G Liverini
Journal:  Int J Obes Relat Metab Disord       Date:  2002-01

4.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.

Authors:  Yong-Xu Wang; Chih-Hao Lee; Sambath Tiep; Ruth T Yu; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

5.  Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.

Authors:  S I Itani; Q Zhou; W J Pories; K G MacDonald; G L Dohm
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

6.  Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.

Authors:  Arend Bonen; Michelle L Parolin; Gregory R Steinberg; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; George J F Heigenhauser; David J Dyck
Journal:  FASEB J       Date:  2004-05-07       Impact factor: 5.191

7.  Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity.

Authors:  Kyle L Hoehn; Nigel Turner; Michael M Swarbrick; Donna Wilks; Elaine Preston; Yuwei Phua; Himani Joshi; Stuart M Furler; Mark Larance; Bronwyn D Hegarty; Simon J Leslie; Russell Pickford; Andrew J Hoy; Edward W Kraegen; David E James; Gregory J Cooney
Journal:  Cell Metab       Date:  2010-01       Impact factor: 27.287

8.  Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle.

Authors:  Henriette Pilegaard; Bengt Saltin; P Darrell Neufer
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

9.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

10.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.

Authors:  Mary Elizabeth Patti; Atul J Butte; Sarah Crunkhorn; Kenneth Cusi; Rachele Berria; Sangeeta Kashyap; Yoshinori Miyazaki; Isaac Kohane; Maura Costello; Robert Saccone; Edwin J Landaker; Allison B Goldfine; Edward Mun; Ralph DeFronzo; Jean Finlayson; C Ronald Kahn; Lawrence J Mandarino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 12.779

View more
  32 in total

Review 1.  Physical activity-induced remodeling of vasculature in skeletal muscle: role in treatment of type 2 diabetes.

Authors:  M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2015-10-15

2.  Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.

Authors:  Melissa A Linden; Ryan D Sheldon; Grace M Meers; Laura C Ortinau; E Matthew Morris; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter; James R Sowers; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

3.  Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Med Sci Sports Exerc       Date:  2015-03       Impact factor: 5.411

4.  Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats.

Authors:  Melissa A Linden; Kristi T Lopez; Justin A Fletcher; E Matthew Morris; Grace M Meers; Sameer Siddique; M Harold Laughlin; James R Sowers; John P Thyfault; Jamal A Ibdah; R Scott Rector
Journal:  Appl Physiol Nutr Metab       Date:  2015-06-24       Impact factor: 2.665

5.  Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.

Authors:  Justin A Fletcher; Melissa A Linden; Ryan D Sheldon; Grace M Meers; E Matthew Morris; Anthony Butterfield; James W Perfield; R Scott Rector; John P Thyfault
Journal:  Exp Physiol       Date:  2018-01-16       Impact factor: 2.969

6.  Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; Monica L Kearney; Jacqueline M Crissey; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

7.  Voluntary Running Attenuates Metabolic Dysfunction in Ovariectomized Low-Fit Rats.

Authors:  Young-Min Park; Jaume Padilla; Jill A Kanaley; Terese M Zidon; Rebecca J Welly; Steven L Britton; Lauren G Koch; John P Thyfault; Frank W Booth; Victoria J Vieira-Potter
Journal:  Med Sci Sports Exerc       Date:  2017-02       Impact factor: 5.411

8.  Simvastatin impairs exercise training adaptations.

Authors:  Catherine R Mikus; Leryn J Boyle; Sarah J Borengasser; Douglas J Oberlin; Scott P Naples; Justin Fletcher; Grace M Meers; Meghan Ruebel; M Harold Laughlin; Kevin C Dellsperger; Paul J Fadel; John P Thyfault
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

9.  A return to ad libitum feeding following caloric restriction promotes hepatic steatosis in hyperphagic OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; Grace M Meers; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-07-21       Impact factor: 4.052

10.  Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats.

Authors:  Ryan D Sheldon; M Harold Laughlin; R Scott Rector
Journal:  J Appl Physiol (1985)       Date:  2014-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.